IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57 | 0.0% | 1,378 | 0.0% | 0.00% | – |
| Q2 2023 | $57 | +16.3% | 1,378 | 0.0% | 0.00% | – |
| Q1 2023 | $49 | -19.7% | 1,378 | 0.0% | 0.00% | – |
| Q4 2022 | $61 | -99.9% | 1,378 | 0.0% | 0.00% | – |
| Q3 2022 | $61,000 | +19.6% | 1,378 | 0.0% | 0.00% | – |
| Q2 2022 | $51,000 | -82.9% | 1,378 | -82.9% | 0.00% | -100.0% |
| Q1 2022 | $298,000 | +22.1% | 8,039 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $244,000 | -18.4% | 8,017 | -10.0% | 0.00% | 0.0% |
| Q3 2021 | $299,000 | -68.3% | 8,912 | -62.3% | 0.00% | -50.0% |
| Q2 2021 | $942,000 | -9.1% | 23,622 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $1,036,000 | -85.8% | 23,022 | -1.7% | 0.00% | -33.3% |
| Q4 2020 | $7,283,000 | +554.9% | 23,422 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,112,000 | -19.5% | 23,422 | 0.0% | 0.00% | -40.0% |
| Q2 2020 | $1,381,000 | +166.1% | 23,422 | +113.5% | 0.01% | +25.0% |
| Q1 2020 | $519,000 | -13.1% | 10,971 | +11.1% | 0.00% | 0.0% |
| Q4 2019 | $597,000 | +4.0% | 9,875 | +3.0% | 0.00% | 0.0% |
| Q3 2019 | $574,000 | +1025.5% | 9,586 | +1105.8% | 0.00% | – |
| Q2 2019 | $51,000 | -21.5% | 795 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $65,000 | +51.2% | 795 | 0.0% | 0.00% | – |
| Q4 2018 | $43,000 | +4.9% | 795 | 0.0% | 0.00% | – |
| Q3 2018 | $41,000 | -63.1% | 795 | -70.2% | 0.00% | -100.0% |
| Q2 2018 | $111,000 | +1.8% | 2,664 | +7.0% | 0.00% | 0.0% |
| Q1 2018 | $109,000 | +16.0% | 2,489 | +33.2% | 0.00% | 0.0% |
| Q4 2017 | $94,000 | -1.1% | 1,869 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $95,000 | 0.0% | 1,869 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $95,000 | +26.7% | 1,869 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $75,000 | -15.7% | 1,869 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $89,000 | -83.9% | 1,869 | -87.6% | 0.00% | -85.7% |
| Q3 2016 | $554,000 | +172.9% | 15,107 | +73.1% | 0.01% | +133.3% |
| Q2 2016 | $203,000 | -42.7% | 8,729 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $354,000 | -43.5% | 8,729 | -13.7% | 0.01% | -50.0% |
| Q4 2015 | $626,000 | – | 10,110 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |